Exagen Inc. Reports Second Quarter 2026 Financial Results
Go back to Exagen Inc. Reports Second Quarter 2026 Financial Results| (NASDAQ: XGN) | Delayed: 6.91 +0.32 (4.86%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $6.59 | 52 Week High | $0.46 | |||
| Open | $6.70 | 52 Week Low | $0.46 | |||
| Day High | $6.97 | P/E | N/A | |||
| Day Low | $6.70 | EPS | $0.00 | |||
| Volume | 47,938 | |||||
| (NASDAQ: XGN) | Delayed: 6.91 +0.32 (4.86%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $6.59 | 52 Week High | $0.46 | |||
| Open | $6.70 | 52 Week Low | $0.46 | |||
| Day High | $6.97 | P/E | N/A | |||
| Day Low | $6.70 | EPS | $0.00 | |||
| Volume | 47,938 | |||||

